Preparation of a therapeutic composition
AssigneeAdvanced Viral Research Corp.
InventorsBernard Friedland, Shalom Z. Hirschman
Life of this patent
Estimating the term…
Abstract
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises nucleotides and peptides that have molecular weights not more than 14 KDa and substantially not more than 8 KDa. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.
Claims11
A peptide nucleic acid composition that absorbs light at wavelengths 230 nm, 260 nm and 280 nm so as to result in 260 nm/280 nm absorption ratio of about 1.998 and 260 nm/230 nm absorption ratio of about 1.359, comprising molecules of nucleotides resulting from a plant RNA and pleptides resulting from a mixture of casein, beef peptone and bovine serum albumin, said molecules having non-uniformly distributed molecular weights.
A method for preparing a peptide nucleic acid composition that absorbs light at wavelengths 230 nm, 260 nm and 280 nm so as to result in 260 nm/280 nm absorption ratio of about 1.998 and 260 nm/230 nm absorption ratio of about 1,359, said composition containing molecules of nucleotides and peptides having non-uniformly distributed molecular weights, comprising the steps of:
- a. forming a mixture including a protein combination consisting oc casein, beef peptone and bovine serum albumin, a plant RNA and a base in water, wherein the ratio of said protein combination to said water is in a range from about 1.5/100 to about 2.5/100 by weight;
- b. processing said mixture at an elevated temperature and an elevated pressure so as to form a solution and insoluble elements;
- c. removing said insoluble elements;
- d. diluting said solution with water;
- and
- e. after performing steps b, c and d, adjusting the pH of said solution to a physiologically acceptable pH.
Dependencies are inferred from the claim text.